May 22, 2026
9 minutes read China’s head and neck cancer treatment has reached globally leading levels in multiple subspecialties: Nasopharyngeal cancer (NPC)…
阅读更多 →
May 22, 2026
9 minutes read China is the country with the largest cervical cancer burden globally — accounting for 23% of global…
阅读更多 →
May 22, 2026
10 minutes read China’s cardiovascular surgery is in a globally leading position — Fuwai Hospital (National Center for Cardiovascular Diseases)…
阅读更多 →
May 22, 2026
10 minutes read Chinese neurosurgery has developed rapidly over the past 20 years, with the establishment of the National Center…
阅读更多 →
May 22, 2026
9 minutes read Radiation therapy (RT) is a core component of oncology treatment in China — approximately 60–70% of cancer…
阅读更多 →
May 22, 2026
8 minutes read Multiple Primary Cancers (MPC) — the occurrence of two or more independent primary tumors in the same…
阅读更多 →
May 22, 2026
10 minutes read Relapsed and refractory (r/r) hematologic malignancies — hematologic cancers that have progressed despite first-line treatment or remain…
阅读更多 →
May 22, 2026
9 minutes read International patients considering medical care in China often ask: “China has so many new drugs and clinical…
阅读更多 →
May 22, 2026
10 minutes read Pediatric oncology has been among China’s most rapidly advancing fields in the past 20 years — the…
阅读更多 →
May 22, 2026
10 minutes read Over the past decade, China has emerged as one of the world’s primary developers of oncology targeted…
阅读更多 →
